Related Experiment Video
Updated: May 9, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
Published on: September 4, 2017
Benchmark dose profiles for joint-action continuous data in quantitative risk assessment
Roland C Deutsch1, Walter W Piegorsch
1Department of Mathematics & Statistics, The University of North Carolina at Greensboro, 317 College Avenue, Greensboro, NC 27402, USA. roland.c.deutsch@gmail.com
Abstract:
Benchmark analysis is a widely used tool in biomedical and environmental risk assessment. Therein, estimation of minimum exposure levels, called benchmark doses (BMDs), that induce a prespecified benchmark response (BMR) is well understood for the case of an adverse response to a single stimulus. For cases where two agents are studied in tandem, however, the benchmark approach is far less developed. This paper demonstrates how the benchmark modeling paradigm can be expanded from the single-agent setting to joint-action, two-agent studies. Focus is on continuous response outcomes. Extending the single-exposure setting, representations of risk are based on a joint-action dose-response model involving both agents. Based on such a model, the concept of a benchmark profile-a two-dimensional analog of the single-dose BMD at which both agents achieve the specified BMR-is defined for use in quantitative risk characterization and assessment.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Dose Response Curve: Conventional Versus Nonmonotonic
Dosage Regimens: Partial Pharmacokinetic Parameters
Dosage Regimen Designs: Nomograms and Tabulations
Quantitative Aspects of Drug-Receptor Interaction
Dose Size and Dosing Frequency: Determination Methods

